The PORTOS assay could indicate when or when not to offer dose-escalated radiation for localized prostate cancer.

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Nearly one in eight men will be diagnosed with prostate cancer and, as a new UCSF study finds, significantly more of these ...

A "Man Van" deployed in disadvantaged communities can help identify men at high risk for prostate cancer, according to a ...

REC’s Ondo ‘indigeneship’ ignites call for removal Warning signs for prostate cancer If you’re facing prostate removal, it’s natural to have many questions and concerns. Radical ...

After an apparent accidental early release, Pfizer has revealed phase 1 data showing its investigational candidate, alongside ...

Serum testosterone (T) recovery to normal levels is associated with a significant improvement in overall survival in patients ...

Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...

WYFF News 4's Nigel Robertson has spent more than two decades at WYFF and recently shared his cancer journey after a ...

Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...

Prime Minister Netanyahu’s doctors released a medical report detailing the procedures he has undergone and his latest blood ...

After a change in screening guidelines, the incidence increased across the state, surpassing the national trend. A new study ...